2016 Poster Sessions

Spread the love

2016 header

 

The AATOD Conference serves as a central gathering point for the opioid treatment community and offers significant opportunities for exhibiting companies and attendees to interact with other professionals who are devoted to the treatment of opioid dependence throughout the nation and abroad. The registrants will consist of the decision makers in this field who spend over $1 billion annually treating more than 350,000 patients in opioid treatment programs. In order to provide exhibitors with steady exposure to conference attendees, all continental breakfasts and refreshments breaks will be held exclusively in the exhibit area. An Exhibitor’s Networking Event will be held Monday, October 31st to encourage contact and dialogue between opioid treatment professionals and the exhibiting companies.

EXHIBIT HOURS
Sunday, October 30–4:00 p.m.–7:30 p.m.
Monday, October 31–7:30 a.m.–9:30 a.m.; 11:30 a.m.–4:30 p.m.
Tuesday, November 1–7:30 a.m.–1:30 p.m.

Posters are in place at all times when the Grand Ballroom is open. Authors will present their topic on Monday, October 31 from 7:30 a.m.–8:45 a.m. and 3:00 p.m.–4:00 p.m.

The following domestic and international posters will provide valuable research findings to treatment providers:

Effect of Non-Scheduled Urine Tests among All Students in aPrivate High School in Las Vegas
Miriam Adelson, MD

What is “Treatment” in Drug Courts? A Qualitative Study of Treatment Practices in Indiana Drug Court
Barbara Andraka-Christou, JD

Cannabis, The Anti-Gateway Drug?
Angela Bonaguidi, LCSW

Use of Risk Mitigation Practices by Family NursePractitioners Prescribing Opioids for the Management of Chronic Non-Malignant Pain
Sahil Chaudhary, BS Candidate

Implementation of Overdose Education and Naloxone Distribution (OEND)
Emily Daniell, BSN

Racial/Ethnic Differences in Primary Drug used among Entrants to Opioid Treatment Programs over Time
Chunki Fong, MS

Characterizing Opioid and Benzodiazepine Abuse as Reported by Opioid Treatment Programs in the United States
Jody L Green, PhD

Characterizing Opioid and Benzodiazepine Abuse as Reported by Patients Entering Medication-Assisted Substance Abuse Treatment Programs in Europe
Jody L Green, PhD

HUB and Spoke Model of Care
Evan Kletter, PhD

Usefulness of a Brief Educational Event to Challenge Service Providers’ Approaches with Families
Jan Ligon, PhD

A Study of Factors Contributing to Drug Court Graduation
David Masri, PhD

Characteristics and Treatment Outcomes among Pregnant Women Maintained on Buprenorphine vs. Methadone
Krystle McConnell, BA

Decisions in Recovery: Medications for Opioid Addiction – A Web- Based Shared Decision Making Tool
Niki Ann Miller, MS

“No Thanks”: When OTP Patients Refuse a Naloxone Kit for Overdose Prevention
K. Michelle Peavy, PhD

Stress among Methadone Maintenance Treatment Patients, Prevalence and Risk Factors
Einat Peles, PhD

Knowledge about HIV and Risky Behavior among Methadone Maintenance Treatment Patients
Anat Sason, MS

The Effectiveness and Reproducibility of a Learning Collaborative Strategy to Improve Quality of Care for Rural Buprenorphine Patients with Opioid Use Disorders
Elizabeth Saunders, MS

Controlled Substance Monitoring with the Prescription Monitoring Program (PMP) in an Office Based Buprenorphine Program
Julia Shi, MD

How Do Peer Recovery Services Groups Work? An Interactional Analysis
Jo L. Sotheran, PhD

Increasing Access to Hepatitis C Treatment for Opioid Maintained Patients via Telemedicine
Clewert Sylvester, MD

Staff Attitudes and Perceptions Supportive of Overdose Prevention Education in an Opioid Treatment Program
Rosson Wiebe, DNP 

Optimal Minimum Length of Treatment with Buprenorphine: An Analysis of Resource Use and Costs after Medically Controlled Discontinuation
Vladimir Zah, PhD(c)

“Methadone is Making Me Fat!”: Addressing Patients’ Concerns about Methadone and Weight Gain
Cassie Zwart, MSW

Johns Hopkins Cornerstone at Helping Up Mission: A Novel Community-Academic Partnership
Denis Antoine, MD

Combatting Opioid Overdose
Kelly Dunn, PhD

sea